rF1V-1018 vaccine

· Dynavax Technologies Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rF1V-1018 vaccine, covering 2025-10-06 to 2025-10-06. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age [Phase 2]